Literature DB >> 10544585

[Varying clinical picture and course of human granulocytic ehrlichiosis. Twelve Scandinavian cases of the new tick-borne zoonosis are presented].

A Bjöersdorff1, J Berglund, B E Kristiansen, C Söderström, I Eliasson.   

Abstract

In the twelve clinical cases of human granulocytic ehrlichiosis (HGE) so far identified in Scandinavia (ten in Sweden, two in Norway), clinical presentation varied from a mild febrile illness to a severe septic condition with such systemic complications as acute respiratory distress syndrome (ARDS). Laboratory verification was based on PCR (polymerase chain reaction) in ten cases, and on serology in two cases. Sequence analysis of 16S rDNA showed the infectious agents to belong to the Ehrlichia phagocytophila genogroup. Seroprevalence data indicate widespread human exposure to granulocytic Ehrlichia; mean seroprevalence, 15-20% of 1,000 clinical sera from tick-exposed patients (mainly from Sweden and Norway). Proposals for diagnostic criteria and procedures, and case management are presented in the article.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544585

Source DB:  PubMed          Journal:  Lakartidningen        ISSN: 0023-7205


  10 in total

1.  Contribution of polymorphisms in ankA, gltA, and groESL in defining genetic variants of Anaplasma phagocytophilum.

Authors:  Sanjay K Shukla; Vijay Aswani; Patrick J Stockwell; Kurt D Reed
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948

Review 2.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  PCR detection and serological evidence of granulocytic ehrlichial infection in roe deer (Capreolus capreolus) and chamois (Rupicapra rupicapra).

Authors:  Jorge S Liz; John W Sumner; Kurt Pfister; Michel Brossard
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  High prevalence of granulocytic Ehrlichiae and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Bulgaria.

Authors:  I Christova; L Schouls; I van De Pol; J Park; S Panayotov; V Lefterova; T Kantardjiev; J S Dumler
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia.

Authors:  S Lotric-Furlan; T Avsic-Zupanc; M Petrovec; W L Nicholson; J W Sumner; J E Childs; F Strle
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

6.  Detection of antibodies to Anaplasma phagocytophilum and Ehrlichia chaffeensis antigens in sera of Korean patients by western immunoblotting and indirect immunofluorescence assays.

Authors:  Jin-Ho Park; Eun-Jeong Heo; Kyoung-Seong Choi; J Stephen Dumler; Joon-Seok Chae
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

7.  Spread of ticks and tick-borne diseases in Germany due to global warming.

Authors:  Kathrin Hartelt; Silvia Pluta; Rainer Oehme; Peter Kimmig
Journal:  Parasitol Res       Date:  2008-11-23       Impact factor: 2.289

8.  Serological reactivity to Anaplasma phagocytophilum in neoehrlichiosis patients.

Authors:  Linda Wass; Anna Grankvist; Mattias Mattsson; Helena Gustafsson; Karen Krogfelt; Björn Olsen; Kenneth Nilsson; Andreas Mårtensson; Hanne Quarsten; Anna J Henningsson; Christine Wennerås
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-14       Impact factor: 3.267

9.  Prevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in questing Ixodes ricinus ticks in relation to the density of wild cervids.

Authors:  Olav Rosef; Algimantas Paulauskas; Jana Radzijevskaja
Journal:  Acta Vet Scand       Date:  2009-11-27       Impact factor: 1.695

Review 10.  Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis.

Authors:  Rachael J Thomas; J Stephen Dumler; Jason A Carlyon
Journal:  Expert Rev Anti Infect Ther       Date:  2009-08       Impact factor: 5.854

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.